RadNet, Inc.
RDNT
주식 순위
#3236
RadNet, Inc. operates as a prominent healthcare services company specializing... RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
주가
$69.77
시가총액
$5.49B
변동 (1일)
0.72%
변동 (1년)
-11.05%
국가
US
거래 RadNet, Inc. (RDNT)
카테고리
Healthcare
RadNet, Inc. (RDNT)의 매출
Jun 2026 기준 매출 TTM: $2.27B
RadNet, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $2.27B입니다. 2023년에 회사는 $1.62B의 수익을 올렸으며 이는 2022년의 $1.43B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
RadNet, Inc.의 수익 기록 (2000 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $2.27B | 24.01% |
| 2024 | $1.83B | 13.18% |
| 2023 | $1.62B | 13.05% |
| 2022 | $1.43B | 8.74% |
| 2021 | $1.32B | 22.69% |
| 2020 | $1.07B | -7.13% |
| 2019 | $1.15B | 18.36% |
| 2018 | $975.15M | 5.74% |
| 2017 | $922.19M | 4.26% |
| 2016 | $884.54M | 9.25% |
| 2015 | $809.63M | 12.83% |
| 2014 | $717.57M | 2.07% |
| 2013 | $702.99M | 8.63% |
| 2012 | $647.15M | 4.41% |
| 2011 | $619.80M | 12.99% |
| 2010 | $548.54M | 4.61% |
| 2009 | $524.37M | 4.43% |
| 2008 | $502.12M | 18.01% |
| 2007 | $425.47M | 164.26% |
| 2006 | $161.01M | 10.60% |
| 2005 | $145.57M | 6.04% |
| 2004 | $137.28M | -2.13% |
| 2003 | $140.26M | 0.70% |
| 2002 | $139.28M | 24.54% |
| 2001 | $111.84M | 27.14% |
| 2000 | $87.96M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $46.34B | 1,942.19% |
US
|
|
| $25.11B | 1,006.56% |
US
|
|
| $2.71B | 19.31% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 224.91% |
US
|
